National Psoriasis Foundation awards more than $2 million for research
Record number of grants and dollars given to study psoriasis and psoriatic arthritis
PORTLAND, Ore. (May 15, 2012)—Twenty-six scientists have received a total of $2.06 million in grants from the National Psoriasis Foundation to study psoriasis—the most common autoimmune disease in the country, affecting as many as 7.5 million Americans—and psoriatic arthritis, an inflammatory joint and tendon disease.
- Eight scientists each received a one-year, $50,000 Discovery Grant, for a total of $400,000, for pilot projects that have great potential to lead to breakthroughs in our understanding of psoriatic diseases and discover better treatments. The grants are also intended to lay the groundwork for additional, long-term funding from the National Institutes of Health and other funding agencies. Learn about the National Psoriasis Foundation Discovery Grant recipients and their projects »
- Six scientists each received a two-year, $200,000 Translational Research Grant, for a total of $1.2 million, for studies that aim to move laboratory and clinical discoveries into projects and treatments that benefit patients. Read about the Translational Research Grant recipients and their work »
- Twelve early-career physicians were awarded a Psoriasis Foundation medical research fellowship, totaling $465,000. These fellowships provide support of up to $40,000 per year to new doctors training to do research in psoriasis and psoriatic arthritis. They are intended to increase the number of doctors studying psoriatic diseases. Meet the National Psoriasis Foundation Research Fellows »
"National Psoriasis Foundation is committed to funding promising research," said Chip Newton of the National Psoriasis Foundation's Scientific Advisory Committee. "This year, due to a record number of applicants, we awarded the highest number of grants and dollars in our organization's history. Each of these projects has tremendous potential to advance our knowledge of psoriatic diseases, lead to new treatments, and, we hope, even a cure for these diseases."